HSP 65 Inhibitors

HSP65 inhibitors and protein synthesis inhibitors represent two chemical classes that can indirectly affect the function of HSP65. HSP90 inhibitors, such as Geldanamycin, 17-AAG, Tanespimycin, Radicicol, Alvespimycin, Novobiocin, and Oxibendazole, can disrupt the proper folding and stability of proteins. HSP65, as a heat shock protein, is involved in protein folding and stability, so these inhibitors can indirectly affect its function.

Protein synthesis inhibitors, such as Cycloheximide, Chloramphenicol, Rifampicin, Tetracycline, and Erythromycin, can prevent the production of new bacterial proteins. These compounds inhibit the process of transcription or translation, the synthesis of proteins from RNA. By inhibiting this process, these chemicals can affect the production of HSP65, influencing its presence and function within the bacterial cell. Therefore, while these compounds do not directly target HSP65, they can modulate its function by affecting broader bacterial cellular processes involved in the synthesis and folding of proteins.